Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zilucoplan pharmacokinetics study comparing 2 administration methods in healthy adults
NL-OMON58748Phase 1Completed
- Sponsor
- UCB
- Start
- Aug 2024
- Modality
- Cyclic Peptides → Modified Peptides → Peptides
- Countries
- 1
01
Overview
Phase 1 trial of zilucoplan (2 arms), sponsored by UCB. Primary endpoint: Primary endpoint(s). Started Aug 2024; status: completed.
02
Drugs
zilucoplan
Beyond the preview
Go deeper on NL-OMON58748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58748.